ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Shares Down 2.7%

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)’s share price fell 2.7% during mid-day trading on Thursday . The stock traded as low as $18.50 and last traded at $18.59. 3,780 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 19,729 shares. The stock had previously closed at $19.11.

ProShares UltraShort Nasdaq Biotechnology Stock Performance

The stock has a 50-day simple moving average of $18.53 and a 200 day simple moving average of $19.89.

ProShares UltraShort Nasdaq Biotechnology Announces Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, March 27th. Investors of record on Thursday, March 21st were given a dividend of $0.1586 per share. The ex-dividend date of this dividend was Wednesday, March 20th.

Hedge Funds Weigh In On ProShares UltraShort Nasdaq Biotechnology

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. IMC Chicago LLC bought a new stake in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 15,001 shares of the company’s stock, valued at approximately $271,000. IMC Chicago LLC owned about 3.19% of ProShares UltraShort Nasdaq Biotechnology as of its most recent SEC filing.

About ProShares UltraShort Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.